Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Duan, Zhi Yu ^a   Cai, Guang Yan ^a   Bu, Ru ^a   Lu, Yang ^a   Hou, Kai ^a   Chen, Xiang Mei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; URINE;

BIOMARKERS; GLOMERULONEPHRITIS, IGA; HUMANS; MICRORNAS; PROGNOSIS; ROC CURVE;

EID: 84961675397     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23498     Document Type: Article

References (40)

1. Cai, G. Y. & Chen, X. M. Immunoglobulin a nephropathy in China: progress and challenges. Am J Nephrol. 30, 268-273 (2009).
2. Donadio, J. V. & Grande, J. P. IgA nephropathy. N Engl J Med. 347, 738-748 (2002).
3. Kloosterman, W. P. & Plasterk, R. H. The diverse functions of microRNAs in animal development and disease. Dev Cell. 11, 441-450 (2006).
4. Wang, G. et al. Expression of microRNAs in the urinary sediment of patients with IgA nephropathy. Dis Markers. 28, 79-86 (2010).
5. Wang, G. et al. Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy. Disease Markers. 30, 171-179 (2011).
6. th edition. Vol. IV Ch. 8 (eds Martin, H. et al.), 428-429 (Churchill Livingstone, 2008).
7. Goh, S. H., Lee, Y. T., Bouffard, G. G. & Miller, J. L. Hembase: browser and genome portal for hematology and erythroid biology. Nucleic Acids Res. 32, D572-574 (2004).
8. Chen, S. Y., Wang, Y., Telen, M. J. & Chi, J. T. The genomic analysis of erythrocyte microRNA expression in sickle cell diseases. PLoS one. 3, e2360 (2008).
9. Kannan, M. & Atreya, C. Differential profiling of human red blood cells during storage for 52 selected microRNAs. Transfusion. 50, 1581-1588 (2010).
10. D'Amico, G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis. 36, 227-237 (2000).
11. Szeto, C. C. & Li, P. K. MicroRNAs in IgA nephropathy. Nat Rev Nephrol. 10, 249-256 (2014).
12. Marchi, S. et al. Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25. Curr Biol. 23, 58-63 (2013).
13. Zhang, H. et al. MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer. Oncol Rep. 27, 594-608 (2012).
14. Zhang, L. Y. et al. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Carcinogenesis. 34, 454-463 (2013).
15. Song, L. et al. MiR-486 sustains NF-κ B activity by disrupting multiple NF-κ B-negative feedback loops. Cell Res. 23, 274-289 (2013).
16. Xu, J. et al. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486. Kidney Int. 82, 401-411 (2012).
17. Wu, H. et al. MiR-135a targets JAK2 and inhibits gastric cancer cell proliferation. Cancer Biol Ther. 13, 281-288 (2012).
18. Navarro, A. et al. Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma. Blood. 114, 2945-2951 (2009).
19. Zhou, H. et al. MiR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1. J Am Soc Nephrol. 24, 1073-1087 (2013).
20. Li, P. et al. MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1. Cardiovasc Res. 99, 185-193 (2013).
21. Zhang, J. F. et al. MicroRNA-25 negatively regulates cerebral ischemia/reperfusion injury-Induced cell apoptosis through fas/fasL pathway. J Mol Neurosci. 2016 Jan 14. doi: 10.1007/s12031-016-0712-0.
22. Wang, C. et al. Serum IgA1 from IgA nephropathy patients induces apoptosis in podocytes through direct and indirect pathways. Clin Invest Med. 30, E240-249 (2007).
23. Huo, F., Zhang, C., He, H. & Wang, Y. MicroRNA-144-3p inhibits proliferation and induces apoptosis of human salivary adenoid carcinoma cells via targeting of mTOR. Biotechnol Lett. 38, 409-416(2016).
24. Tian, J. et al. Rapamycin slows IgA nephropathy progression in the rat. Am J Nephrol. 39, 218-229 (2014).
25. Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 9, 654-659 (2007).
26. Vlassov, A. V., Magdaleno, S., Setterquist, R. & Conrad, R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim Biophys Acta. 1820, 940-948 (2012).
27. Cantaluppi, V. et al. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int. 82, 412-427 (2012).
28. Lötvall, J. et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracellular Vesicles. 3, 26913 (2014).
29. Shah, M. D., Bergeron, A. L., Dong, J. F. & López, J. A. Flow cytometric measurement of microparticles: pitfalls and protocol modifications. Platelets. 19, 365-370 (2008).
30. Allan, D., Limbrick, A. R., Thomas, P. & Westerman, M. P. Release of spectrin-free spicules on reoxygenation of sickled erythrocytes. Nature. 295, 612-623 (1982).
31. Lamchiagdhase, P. et al. Red blood cell vesicles in thalassemia. J Med Assoc Thai. 87, 233-238 (2004).
32. Pattanapanyasat, K. et al. Flow cytometric quantitation of red blood cell vesicles in thalassemia. Cytometry B Clin Cytom. 57, 23-31 (2004).
33. Nantakomol, D. et al. Circulating red cell-derived microparticles in human malaria. J Infect Dis. 203, 700-706 (2011).
34. Tan, K. et al. Genome-wide analysis of microRNAs expression profiling in patients with primary IgA nephropathy. Genome. 56, 161-169 (2013).
35. Stevens, L. A. et al. Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int. 79, 555-562 (2011).
36. Szeto, C. C. et al. Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases. Dis Markers. 33, 137-144 (2012).
37. Serino, G. et al. Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy. J Am Soc Nephrol. 23, 814-824 (2012).
38. Qi, W. et al. Isolation, propagation and characterization of primary tubule cell culture from human kidney. Nephrology (Carlton). 12, 155-169 (2007).
39. Hogan, M. C. et al. Subfractionation, characterization, and in-depth proteomic analysis of glomerular membrane vesicles in human urine. Kidney Int. 85, 1225-1237 (2014).
40. Liu, R. et al. A five-microRNA signature identified from genomewide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer. 47, 784-791 (2011).